中慧生物-B(02627)

29.320+0.0000.00%

社区社区
资讯资讯
资料资料
公告公告

- 最新
- 推荐
公司概况
公司名称
中慧生物-B
所属市场
SEHK
成立日期
- -
员工人数
- -
办公地址
- -
公司网址
http://www.abbbio.com
邮政编码
- -
联系电话
- -
联系传真
- -
公司概况
江苏中慧元通生物科技股份有限公司是一家主要从事疫苗的研发、制造及商业化中国公司。该公司的产品管线包括两种核心产品，即四价流感病毒亚单位疫苗及在研冻干人用狂犬病疫苗，以及其他11种在研疫苗。该公司主要在中国市场开展业务。
- 02-26
  业绩预告
  盈利预告 - 预期亏损减少
  盈利预告 - 预期亏损减少
- 2025-09-29
  半年度报告
  2025中期报告
  2025中期报告
- 2025-08-28
  半年度报告
  截至2025年6月30日止六个月的中期业绩公告
  截至2025年6月30日止六个月的中期业绩公告
- 2025-07-31
  股份发售
  全球发售
  全球发售

分时
5日
日
周
月

数据加载中...

最高

29.320

今开

29.320

量比

0.00

最低

29.320

昨收

29.320

换手率

0.00%

热议股票

{"pagemeta":{"title":"中慧生物-B(02627)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供中慧生物-B(02627)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"中慧生物-B,02627,中慧生物-B股票,中慧生物-B股票老虎,中慧生物-B股票老虎国际,中慧生物-B行情,中慧生物-B股票行情,中慧生物-B股价,中慧生物-B股市,中慧生物-B股票价格,中慧生物-B股票交易,中慧生物-B股票购买,中慧生物-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"中慧生物-B(02627)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供中慧生物-B(02627)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}},"tab":"community","symbol":"02627","data":{"stockData":{"symbol":"02627","market":"HK","secType":"STK","nameCN":"中慧生物-B","latestPrice":29.32,"timestamp":1779326405257,"preClose":29.32,"halted":3,"volume":0,"delay":0,"changeRate":0,"floatShares":296361845,"shares":393000000,"eps":-0.8274408046868269,"marketStatus":"停牌","change":0,"latestTime":"05-21 13:13:10","open":29.32,"high":29.32,"low":29.32,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.7196088567243903,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1779351000000},"marketStatusCode":2,"adr":0,"listingDate":1754841600000,"exchange":"SEHK","adjPreClose":29.32,"openAndCloseTimeList":[[1779327000000,1779336000000],[1779339600000,1779350400000]],"volumeRatio":0,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"tweetData":{"bottom":false,"list":[{"cardType":"TWEET","cardId":"TWEET.566479246742568","cardData":[{"tweetId":"566479246742568","author":{"authorId":"4229585084866080","idStr":"4229585084866080","name":"道友 请留步","avatar":"https://static.tigerbbs.com/6c24949cbaec88eea6fc2fa455a1603e","userType":1,"introduction":"","crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[],"fanSize":0,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"title":"","digest":"<a href=\"https://laohu8.com/S/02627\">$中慧生物-B(02627)$ </a> 中慧目前还是比较稳定的推进复牌工作，公司也在努力啊","plainDigest":"$中慧生物-B(02627)$ 中慧目前还是比较稳定的推进复牌工作，公司也在努力啊","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1779334915576,"gmtModify":1779334917676,"symbols":["02627"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":44,"likeCount":0,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/566479246742568","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":68,"displayRows":4,"foldSize":0,"authorId":"4229585084866080"}]},{"cardType":"TWEET","cardId":"TWEET.566211532797552","cardData":[{"tweetId":"566211532797552","author":{"authorId":"4218427800237090","idStr":"4218427800237090","name":"莎士比亚的微笑","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","userType":1,"introduction":"","crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[],"fanSize":5,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"title":"","digest":"<a href=\"https://laohu8.com/S/02627\">$中慧生物-B(02627)$ </a> 除流感疫苗外，公司管线还包括在研冻干人用狂犬病疫苗等11种在研疫苗，展现了未来持续成长的潜力。","plainDigest":"$中慧生物-B(02627)$ 除流感疫苗外，公司管线还包括在研冻干人用狂犬病疫苗等11种在研疫苗，展现了未来持续成长的潜力。","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1779269617292,"gmtModify":1779269619315,"symbols":["02627"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":40,"likeCount":1,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/566211532797552","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":108,"displayRows":4,"foldSize":0,"authorId":"4218427800237090"}]},{"cardType":"TWEET","cardId":"TWEET.565760414221576","cardData":[{"tweetId":"565760414221576","author":{"authorId":"4229585084866080","idStr":"4229585084866080","name":"道友 请留步","avatar":"https://static.tigerbbs.com/6c24949cbaec88eea6fc2fa455a1603e","userType":1,"introduction":"","crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[],"fanSize":0,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"title":"","digest":"<a href=\"https://laohu8.com/S/02627\">$中慧生物-B(02627)$ </a> 中慧现在复牌的工作应该是有序进行之中，等着早点复牌就可以了","plainDigest":"$中慧生物-B(02627)$ 中慧现在复牌的工作应该是有序进行之中，等着早点复牌就可以了","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1779159430549,"gmtModify":1779159432734,"symbols":["02627"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":47,"likeCount":1,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/565760414221576","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":76,"displayRows":4,"foldSize":0,"authorId":"4229585084866080"}]},{"cardType":"TWEET","cardId":"TWEET.565492760617040","cardData":[{"tweetId":"565492760617040","author":{"authorId":"4203843771083212","idStr":"4203843771083212","name":"乐山大佛笑哈哈","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","userType":1,"introduction":"","crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[],"fanSize":2,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"title":"","digest":"<a href=\"https://laohu8.com/S/02627\">$中慧生物-B(02627)$ </a> 公司2025年IPO募资剩余资金约1.28亿港元，且流感疫苗“慧尔康欣3”已实现商业化，短期运营资金压力较小。","plainDigest":"$中慧生物-B(02627)$ 公司2025年IPO募资剩余资金约1.28亿港元，且流感疫苗“慧尔康欣3”已实现商业化，短期运营资金压力较小。","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1779094165930,"gmtModify":1779094168352,"symbols":["02627"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":68,"likeCount":1,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/565492760617040","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":112,"displayRows":4,"foldSize":0,"authorId":"4203843771083212"}]},{"cardType":"TWEET","cardId":"TWEET.564368595285264","cardData":[{"tweetId":"564368595285264","author":{"authorId":"4229664385867060","idStr":"4229664385867060","name":"仓都嘉满","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","userType":1,"introduction":"","crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[],"fanSize":1,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"title":"","digest":"<a href=\"https://laohu8.com/S/02627\">$中慧生物-B(02627)$ </a> 创新药短期内还没有完全轮动起来，中慧趁机可以多做些准备工作，等复牌后就看刺激市场啦","plainDigest":"$中慧生物-B(02627)$ 创新药短期内还没有完全轮动起来，中慧趁机可以多做些准备工作，等复牌后就看刺激市场啦","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1778819631092,"gmtModify":1778819633268,"symbols":["02627"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":71,"likeCount":1,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/564368595285264","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":99,"displayRows":4,"foldSize":0,"authorId":"4229664385867060"}]},{"cardType":"TWEET","cardId":"TWEET.564072676855936","cardData":[{"tweetId":"564072676855936","author":{"authorId":"4193625296607780","idStr":"4193625296607780","name":"打铁不如李铁","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","userType":1,"introduction":"","crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[],"fanSize":6,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"title":"","digest":"<a href=\"https://laohu8.com/S/02627\">$中慧生物-B(02627)$ </a> RSV是老年人与慢性病患者重症主因，中国尚无上市疫苗，中慧生物产品若成功上市，有望填补千亿级空白","plainDigest":"$中慧生物-B(02627)$ RSV是老年人与慢性病患者重症主因，中国尚无上市疫苗，中慧生物产品若成功上市，有望填补千亿级空白","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1778747466428,"gmtModify":1778747468787,"symbols":["02627"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":131,"likeCount":1,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/564072676855936","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":109,"displayRows":4,"foldSize":0,"authorId":"4193625296607780"}]},{"cardType":"TWEET","cardId":"TWEET.563641709066000","cardData":[{"tweetId":"563641709066000","author":{"authorId":"156361281180936","idStr":"156361281180936","name":"老油条的原则","avatar":"https://static.tigerbbs.com/504d0a0773c54de999742532a85f54b9","userType":1,"introduction":"","crmLevel":1,"crmLevelSwitch":0,"wearingBadge":{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","individualDisplayEnabled":0,"individualDisplaySort":0},"individualDisplayBadges":[],"wearingBadges":[{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","name":"实盘交易者","description":"完成一笔实盘交易","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","isScarce":0,"effectEnabled":0,"redirectLinkEnabled":0,"redirectLinkValidityFrom":0,"redirectLinkValidityTo":9223372036854776000}],"fanSize":7,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"title":"","digest":"<a href=\"https://laohu8.com/S/02627\">$中慧生物-B(02627)$ </a> 目前在中国，RSV感染的治疗仍依赖广谱抗病毒药物及对症治疗。因此，迫切需要开发一种有效的RSV疫苗，中慧的慧尔康欣填补了这个空缺","plainDigest":"$中慧生物-B(02627)$ 目前在中国，RSV感染的治疗仍依赖广谱抗病毒药物及对症治疗。因此，迫切需要开发一种有效的RSV疫苗，中慧的慧尔康欣填补了这个空缺","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1778642229271,"gmtModify":1778642231466,"symbols":["02627"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":259,"likeCount":1,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/563641709066000","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":137,"displayRows":4,"foldSize":0,"authorId":"156361281180936"}]},{"cardType":"TWEET","cardId":"TWEET.563411638100944","cardData":[{"tweetId":"563411638100944","author":{"authorId":"4184381897673700","idStr":"4184381897673700","name":"曼曼在海南","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","userType":1,"introduction":"","crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[],"fanSize":9,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"title":"","digest":"<a href=\"https://laohu8.com/S/02627\">$中慧生物-B(02627)$ </a> 也许在股东大会决议后就会看到一个完全不同的中慧形象了","plainDigest":"$中慧生物-B(02627)$ 也许在股东大会决议后就会看到一个完全不同的中慧形象了","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1778571246342,"gmtModify":1778571248317,"symbols":["02627"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":263,"likeCount":1,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/563411638100944","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":71,"displayRows":4,"foldSize":0,"authorId":"4184381897673700"}]},{"cardType":"TWEET","cardId":"TWEET.563086551012688","cardData":[{"tweetId":"563086551012688","author":{"authorId":"4229585084866080","idStr":"4229585084866080","name":"道友 请留步","avatar":"https://static.tigerbbs.com/6c24949cbaec88eea6fc2fa455a1603e","userType":1,"introduction":"","crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[],"fanSize":0,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"title":"","digest":"<a href=\"https://laohu8.com/S/02627\">$中慧生物-B(02627)$ </a> 中慧mRNA疫苗已在临床研究中显示出诱导强烈的细胞免疫反应及持久的体液免疫，使其成为保护老年人及免疫功能低下人群免受RSV引起的严重下呼吸道感染的一项具前景选择","plainDigest":"$中慧生物-B(02627)$ 中慧mRNA疫苗已在临床研究中显示出诱导强烈的细胞免疫反应及持久的体液免疫，使其成为保护老年人及免疫功能低下人群免受RSV引起的严重下呼吸道感染的一项具前景选择","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1778500940213,"gmtModify":1778500942514,"symbols":["02627"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":267,"likeCount":1,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/563086551012688","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":171,"displayRows":4,"foldSize":0,"authorId":"4229585084866080"}]},{"cardType":"TWEET","cardId":"TWEET.561906234230656","cardData":[{"tweetId":"561906234230656","author":{"authorId":"4218363023229180","idStr":"4218363023229180","name":"电白小白15","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","userType":1,"introduction":"","crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[],"fanSize":4,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"title":"","digest":"<a href=\"https://laohu8.com/S/02627\">$中慧生物-B(02627)$ </a> 中慧的底子框架足够稳，不惧网上一些无根据的猜测","plainDigest":"$中慧生物-B(02627)$ 中慧的底子框架足够稳，不惧网上一些无根据的猜测","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1778215915771,"gmtModify":1778215917968,"symbols":["02627"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":152,"likeCount":1,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/561906234230656","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":64,"displayRows":4,"foldSize":0,"authorId":"4218363023229180"}]}],"size":10},"newsData":null,"noticeData":{"listData":[{"cdn_pdf":true,"hasAttachments":false,"id":"20767790","market":"hk","labels":[],"media":"港交所","original_id":"N.HKHg4QTNSKDV","pdf_url":"https://static.tigerbbs.com/e8d830bbe24249b680135c6259af3af6","pub_time":1772095380000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"盈利预告 - 预期亏损减少","symbol":"02627","title":"盈利预告 - 预期亏损减少","titleType":"业绩预告","type":"hkFinancials","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2026/0226/2026022600422_c.pdf","us_notice_code":"公告及通告 - [内幕消息 / 盈利警告]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Earnings Estimation","event_type":"important_notice","event_name":"业绩预告","pubTime":"2026-02-26 16:43","pubTimestamp":1772095380,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"20216416","market":"hk","labels":[],"media":"港交所","original_id":"N.HK9C3kk7Se7X","pdf_url":"https://static.tigerbbs.com/cf1b547e64c14210b70191181d1fdddf","pub_time":1759136220000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"2025中期报告","symbol":"02627","title":"2025中期报告","titleType":"半年度报告","type":"hkFinancials","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2025/0929/2025092901031_c.pdf","us_notice_code":"财务报表/环境、社会及管治资料 - [中期/半年度报告]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Interim Report","event_type":"important_notice","event_name":"半年度报告","pubTime":"2025-09-29 16:57","pubTimestamp":1759136220,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"20081459","market":"hk","labels":[],"media":"港交所","original_id":"N.HK3nC81iwMpW","pdf_url":"https://static.tigerbbs.com/c5e2ea97fbfe438884aea43f483d8550","pub_time":1756369860000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"截至2025年6月30日止六个月的中期业绩公告","symbol":"02627","title":"截至2025年6月30日止六个月的中期业绩公告","titleType":"半年度报告","type":"hkFinancials","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2025/0828/2025082800528_c.pdf","us_notice_code":"公告及通告 - [中期业绩]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Interim Report","event_type":"important_notice","event_name":"半年度报告","pubTime":"2025-08-28 16:31","pubTimestamp":1756369860,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"19928517","market":"hk","labels":[],"media":"港交所","original_id":"N.HK3n4S3pGa5T","pdf_url":"https://static.tigerbbs.com/1689af1937184239b2689120903e2c09","pub_time":1753914060000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"全球发售","symbol":"02627","title":"全球发售","titleType":"股份发售","type":"hkIPO","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2025/0731/2025073100088_c.pdf","us_notice_code":"上市文件 - [发售以供认购]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"上市文件","type_name_en":"Listing Document","titleTypeEn":"Shares Subscription","event_type":"important_notice","event_name":"股份发售","pubTime":"2025-07-31 06:21","pubTimestamp":1753914060,"notice_type":"","filling_tag":"","gpt_icon":0}],"currentPage":1,"bottom":true},"companyData":{"profile":{"websiteUrl":"http://www.abbbio.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":-0.4847},{"period":"6month","weight":-0.2717},{"period":"1year","weight":1.2729},{"period":"ytd","weight":-0.2714}],"compareEarnings":[{"period":"1week","weight":-0.0279},{"period":"1month","weight":-0.0269},{"period":"3month","weight":-0.0395},{"period":"6month","weight":0.0171},{"period":"1year","weight":0.0832},{"period":"ytd","weight":0.0008}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"江苏中慧元通生物科技股份有限公司是一家主要从事疫苗的研发、制造及商业化中国公司。该公司的产品管线包括两种核心产品，即四价流感病毒亚单位疫苗及在研冻干人用狂犬病疫苗，以及其他11种在研疫苗。该公司主要在中国市场开展业务。","exchange":"SEHK","name":"中慧生物-B","nameEN":"AB&B BIO-TECH-B"},"aProfile":null}}}